Atrion CorpNASDAQ:ATRI
- LAST PRICE404.0200
- TODAY'S CHANGE (%)5.0500 (1.2658%)
- Bid / Lots394.3700/ 1
- Ask / Lots400.2600/ 1
- Open / Previous Close405.4000 / 398.9700
- Day Range
- 52 Week Range
- Volume15,324
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATRI |
|---|---|---|
| 09:32 ET | 100 | 405.4 |
| 09:34 ET | 200 | 406.2 |
| 09:52 ET | 200 | 405 |
| 09:57 ET | 1100 | 404.02 |
| 09:59 ET | 100 | 406.22 |
| 10:01 ET | 100 | 405.77 |
| 10:10 ET | 600 | 410.87 |
| 10:12 ET | 458 | 410.98 |
| 10:28 ET | 200 | 404.02 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Atrion Corp | 702.2M | 36.7x | -9.78% |
Silk Road Medical Inc | 691.4M | -12.4x | --- |
OrthoPediatrics Corp | 712.2M | -32.9x | --- |
Treace Medical Concepts Inc | 637.9M | -13.0x | --- |
BioLife Solutions Inc | 763.8M | -11.1x | --- |
Paragon 28 Inc | 743.7M | -15.4x | --- |
Company Information
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Contact Information
- Headquarters
- One Allentown ParkwayALLEN, TX, United States 75002
- Phone
- 972-390-9800
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chairman of the Board of Halkey-Roberts Corporation
- Emile Battat
- President, Chief Executive Officer; President of Halkey-Roberts
- David Battat
- Vice President, Chief Financial Officer, Treasurer, Secretary
- Cindy Ferguson
- Lead Independent Director
- Ronald Spaulding
- Independent Director
- Preston Athey
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $702.2M |
|---|---|
Revenue (TTM) | $169.3M |
Shares Outstanding | 1.8M |
Dividend Yield | 2.18% |
Annual Dividend Rate | 8.8000 USD |
Ex-Dividend Date | 03-14-24 |
Pay Date | 03-29-24 |
Beta | 0.64 |
EPS | $11.02 |
Book Value | $138.01 |
P/E Ratio | 36.7x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | 20.3x |
Operating Margin | 13.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
